News
The White House hopes CMS Administrator Mehmet Oz is its ticket to getting the “Big Beautiful Bill” passed before the Senate ...
Corcept Therapeutics remains a strong buy, with recent stock weakness attributed to put options trading rather than ...
Some jobs feel like a cosmic joke. As millions hustle in demanding roles just to make rent, these professions coast through ...
UroGen Pharma's FDA nod for UGN-102 fuels recovery, but cash burn raises financing risks. Check out why I am maintaining my ...
Q4 2025 Earnings Call Transcript June 24, 2025 FedEx Corporation beats earnings expectations. Reported EPS is $6.07, ...
In the pharmaceutical market, sales and share growth are results of needs based, consultative selling complimented by various other marketing tools and tactics. The promotional, consultative approach ...
The Motley Fool. DATE Tuesday, June 24, 2025, at 5 p.m. EDT CALL PARTICIPANTS President and Chief Executive Officer — Raj ...
The demise of the pharmaceutical sales representative has been greatly exaggerated over the years. But in the wake of the COVID-19 pandemic, there is an even greater need to re-examine the rep's role.
Eversana's suite of commercialisation tools for pharma companies will soon have a new component – cognitive behavioural training tools designed to improve the performance of sales representatives.
In today's digital world, it's never been easier—or more critical—to network. Your online profile isn't just a digital resume ...
Iterum Therapeutics Announces Partnership for Commercialization Services U.S. Commercial Launch of ORLYNVAHTM by Q4 2025; First Oral Penem Available in the U.S. Management to host a conference call at ...
Ordinary Annual General Meeting of Formycon AG approves all proposed resolutions by large majorities
AGM/EGM/MiscellaneousOrdinary Annual General Meeting of Formycon AG approves all proposed resolutions by large majorities 18.06.2025 / 16:43 CET/CESTThe issuer is solely responsible for the content of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results